Cargando…

Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta‐analysis

PURPOSE: Previous studies have provided evidence of the high expression of lactate dehydrogenase (LDH) in multiple solid tumors; however, its prognostic relationship with metastatic prostate cancer (mPCa) remains controversial. We performed a meta‐analysis to better understand the prognostic potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fan, Xiang, Hui, Pang, Zisen, Chen, Zejia, Dai, Jinlong, Chen, Shu, Xu, Bin, Zhang, Tianyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541156/ https://www.ncbi.nlm.nih.gov/pubmed/32452656 http://dx.doi.org/10.1002/cam4.3108

Ejemplares similares

Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer
por: Wang, Bin, et al.
Publicado: (2021)

Prostate cancer risk in patients with melanoma: A systematic review and meta‐analysis
por: Acharya, Prakash, et al.
Publicado: (2020)

PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study
por: Lai, Hung-Cheng, et al.
Publicado: (2014)

Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer
por: Cheng, Huaidong, et al.
Publicado: (2018)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis
por: Wang, Jiwei, et al.
Publicado: (2019)

Age at menarche and epithelial ovarian cancer risk: A meta‐analysis and Mendelian randomization study
por: Yang, Huijun, et al.
Publicado: (2019)

Depression and prostate cancer risk: A Mendelian randomization study
por: Chen, Xiong, et al.
Publicado: (2020)

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group
por: Nagarajan, Rajaram, et al.
Publicado: (2019)

Associations between prostate cancer‐related anxiety and health‐related quality of life
por: Erim, Daniel O., et al.
Publicado: (2020)

Proteomics reveals the function reverse of MPSSS‐treated prostate cancer‐associated fibroblasts to suppress PC‐3 cell viability via the FoxO pathway
por: Zhang, Tingting, et al.
Publicado: (2021)

Prevalence, trends, and outcomes of atrial fibrillation in hospitalized patients with metastatic cancer: findings from a national sample
por: Han, Hedong, et al.
Publicado: (2021)

Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study
por: Wang, Kai, et al.
Publicado: (2019)

Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database
por: Lupo, Philip J, et al.
Publicado: (2015)

Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors
por: Cacioppo, Cara N., et al.
Publicado: (2021)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta‐analysis of patient and study characteristics
por: Bylsma, Lauren C., et al.
Publicado: (2019)

Race, tumor location, and disease progression among low‐risk prostate cancer patients
por: Mygatt, Justin G., et al.
Publicado: (2020)

Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Bao, Shengnan, et al.
Publicado: (2021)

Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population‐based study
por: Mo, Xiaofei, et al.
Publicado: (2021)

Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta‐analysis, and experimental validation
por: Hu, Yiren, et al.
Publicado: (2016)

A Bayesian network meta‐analysis of the efficacy of targeted therapies and chemotherapy for treatment of triple‐negative breast cancer
por: Chen, Huihui, et al.
Publicado: (2018)

Body mass index associated with childhood and adolescent high‐risk B‐cell acute lymphoblastic leukemia risk: A Children’s Oncology Group report
por: Ghosh, Taumoha, et al.
Publicado: (2020)

Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage‐colony stimulating factor and interleukin‐2 surface modified MB49 bladder cancer stem cells vaccine
por: Wang, Chun‐yan, et al.
Publicado: (2017)

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2018)

Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3(Tyr705) phosphorylation
por: Sun, Xiaodong, et al.
Publicado: (2020)

Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry
por: Bluethmann, Shirley M., et al.
Publicado: (2020)

Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta‐analysis
por: Li, Yue, et al.
Publicado: (2019)

AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
por: Zhou, Jiatong, et al.
Publicado: (2020)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

Waist circumference and a body shape index and prostate cancer risk and mortality
por: Jochems, Sylvia H. J., et al.
Publicado: (2021)

External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?
por: Li, Rui, et al.
Publicado: (2021)

Risk of immune‐related pneumonitis for PD1/PD‐L1 inhibitors: Systematic review and network meta‐analysis
por: Huang, Yafang, et al.
Publicado: (2019)

A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE
por: Payne, Heather, et al.
Publicado: (2021)

Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
por: Hibbitts, Emily, et al.
Publicado: (2019)

Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers
por: Elamin, Amany, et al.
Publicado: (2015)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ibe2g9iagmq09vub2og9dqdqpl